FinTechFunding

Genetic Technologies: Acquires EasyDNA for $5.4M

Genetic Technologies Acquires EasyDNA for $5.4M

  • Genetic Technologies (GTG) acquires EasyDNA for around $5.4 million in cash and scrip
  • Under the contract, GTG obtains all of Belhealth’s websites, lab testing and distribution agreements associated with its EasyDNA business
  • EasyDNA sells paternity, oncology and health genomics-based laboratory tests, with agreements across 12 labs in North America, Europe and Asia
  • GTG says it will onboard the existing EasyDNA team, retaining the skills of all employees based in Malta and Australia
  • The company says the acquisition will provide it with the foundation to grow its portfolio of serious disease tests across well-established websites in 40 countries
  • The company closed flat at 0.8 cents per share
Previous article
Dimerix: Receives FDA feedback for DMX-200 trial
Next article
ProciseDx: Raises $13M in Convertible Note Financing
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Lloyds Tests Quantum Computing to Strengthen Fraud Detection

The bank explores advanced tech to tackle money mule networks effectively.Highlights: Lloyds is experimenting with quantum computing for...
FinTech

9fin Secures $170 Million Raise, Valued at $1.3 Billion

The fintech platform enhances its funding to accelerate growth and innovation.Highlights: 9fin raised $170 million in a recent...
FinTech

CommBank Enhances Account Onboarding with Password Chip Scanning

New feature streamlines account setup via mobile app for users.Highlights: CommBank introduces password chip scanning in its mobile...
FinTech

Coinbase Receives Conditional Approval for National Trust Bank Charter

The approval marks a significant step for Coinbase in the financial sector.Highlights: Coinbase secures conditional approval for a...